|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-8-1
|
|
pubmed:abstractText |
To study retrospectively CA 125, CD44, and epithelial membrane antigen (EMA) expression in renal cell carcinoma and their role as prognostic factors. CD44 is a cell adhesion molecule, and CA 125 and EMA are tumor-associated antigens used in the diagnosis and monitoring of the outcome and response to treatment of various human malignancies. Their expression and prognostic significance after resection of renal cell carcinoma have not been adequately studied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
368-73
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12893366-Aged,
pubmed-meshheading:12893366-Aged, 80 and over,
pubmed-meshheading:12893366-Antigens, CD44,
pubmed-meshheading:12893366-CA-125 Antigen,
pubmed-meshheading:12893366-Carcinoma, Renal Cell,
pubmed-meshheading:12893366-Female,
pubmed-meshheading:12893366-Humans,
pubmed-meshheading:12893366-Kidney Neoplasms,
pubmed-meshheading:12893366-Male,
pubmed-meshheading:12893366-Middle Aged,
pubmed-meshheading:12893366-Mucin-1,
pubmed-meshheading:12893366-Multivariate Analysis,
pubmed-meshheading:12893366-Prognosis,
pubmed-meshheading:12893366-Retrospective Studies,
pubmed-meshheading:12893366-Survival Analysis,
pubmed-meshheading:12893366-Tumor Markers, Biological
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article
|
